Outcome in PCNSL patients and its association with PD-L1+ leukocytes in the tumor microenvironment

Acta Oncol. 2022 Jul;61(7):824-829. doi: 10.1080/0284186X.2022.2075239. Epub 2022 May 27.

Authors

Maysaa Abdulla¹, Peter Hollander¹, Cecilia Lindskog¹, Christer Sundström¹, Gunilla Enblad², Leonie Saft³, Rose-Marie Amini¹

Affiliations

¹ Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden.
² Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
³ Department of Oncology and Pathology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.

PMID: 35621149
DOI: 10.1080/0284186X.2022.2075239

No abstract available

Publication types

Letter

MeSH terms

B7-H1 Antigen
Biomarkers, Tumor
Central Nervous System Neoplasms* / pathology
Humans
Lymphocytes, Tumor-Infiltrating / pathology
Lymphoma, Non-Hodgkin*
Tumor Microenvironment

Substances

B7-H1 Antigen
Biomarkers, Tumor